Intelligent Biopsy Platform with Adaptive Aspiration and Real-time Tissue Analysis
Legal Citation
Summary of the Inventive Concept
A next-generation biopsy device that integrates AI-driven navigation, real-time tissue analysis, and adaptive aspiration to optimize sample quality, minimize tissue damage, and enable personalized tissue engineering and regeneration therapies.
Background and Problem Solved
The original biopsy device with aspiration valve, as described in the original patent, has limitations in terms of sample quality and tissue damage. The new inventive concept addresses these limitations by introducing an adaptive aspiration valve that dynamically adjusts suction pressure based on real-time tissue sampling data, ensuring optimal sample quality and minimizing tissue damage.
Detailed Description of the Inventive Concept
The intelligent biopsy platform consists of an adaptive aspiration valve that adjusts suction pressure in real-time based on tissue sampling data, an AI-driven navigation system for precise and efficient sampling, a real-time tissue analysis system with integrated spectrometer and machine learning-based classification algorithm, and a modular design with interchangeable instrument sets and drive units. The platform also features an integrated 3D printing module for in-situ creation of customized tissue scaffolds and implants.
Novelty and Inventive Step
The new claims introduce a paradigm shift in biopsy technology by integrating AI-driven navigation, real-time tissue analysis, and adaptive aspiration, making the original inventive concept obsolete. The inventive step lies in the dynamic adjustment of suction pressure based on real-time tissue sampling data, enabling optimal sample quality and minimizing tissue damage.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include variations in the AI-driven navigation system, such as using different machine learning algorithms or incorporating additional sensors. The real-time tissue analysis system could be modified to include additional analytical techniques, such as Raman spectroscopy or fluorescence microscopy. The modular design could be adapted for use in different medical specialties or applications.
Potential Commercial Applications and Market
The intelligent biopsy platform has significant commercial potential in the medical device industry, particularly in the fields of oncology, neurology, and orthopedics. The platform's ability to optimize sample quality, minimize tissue damage, and enable personalized tissue engineering and regeneration therapies could revolutionize the field of diagnostic medicine and tissue sampling.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B10/0275 |
| A | A61 | A61B10/0283 |
| A | A61 | A61B2010/0208 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically biopsy instrumentation and tissue sampling technologies, requiring expertise in mechanical design, medical instrumentation, fluid dynamics, and advanced sensing systems
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with advanced degree, 3-5 years experience in medical device design, familiar with surgical instrumentation, fluid control systems, and emerging diagnostic technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD's adaptive aspiration and AI-driven navigation represent predictable technological extensions of the source patent's fundamental biopsy device architecture. The core mechanical principles of tissue sampling and valve control remain consistent, with the PTD introducing incremental improvements in sensing, control, and data integration. These variations represent natural technological progression using known techniques in medical device engineering.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,171 |
|---|---|
| Title | Biopsy device with aspiration valve |
| Assignee(s) | Hologic, Inc. |